The non-cardiac use and significance of cardiac troponins

Scottish Medical Journal

Volumn 59, Issue 3, 2014, Pages 172-178

  Mannu, Gurdeep Singh ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute coronary syndrome (ACS); Cardiac enzymes; Differential diagnosis; Myocardium; Troponin

Indexed keywords

ANISTREPLASE; CREATINE KINASE; LACTATE DEHYDROGENASE; TROPONIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; APACHE; ARTICLE; BLOOD LEVEL; BLOOD TROPONIN LEVEL; CRITICALLY ILL PATIENT; END STAGE RENAL DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; MYOCARDITIS; PERICARDITIS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; THORAX PAIN; ACUTE CORONARY SYNDROME (ACS); BLOOD; CARDIAC ENZYMES; DIFFERENTIAL DIAGNOSIS; HEART DISEASE; HEART MUSCLE; HISTORY; KIDNEY DISEASE; REVIEW;

ACUTE CORONARY SYNDROME (ACS); CARDIAC ENZYMES; DIFFERENTIAL DIAGNOSIS; MYOCARDIUM; TROPONIN;

BIOLOGICAL MARKERS; CREATINE KINASE; HEART DISEASES; HISTORY, 20TH CENTURY; HUMANS; KIDNEY DISEASES; PULMONARY EMBOLISM; SEPSIS; TROPONIN I; TROPONIN T;

EID: 84908021161     PISSN: 00369330     EISSN: 20456441     Source Type: Journal    
DOI: 10.1177/0036933014540090     Document Type: Article

References (43)

1. Agress CM, Jacobs HI, Glassner HF, et al. Serum transaminase levels in experimental myocardial infarction. Circulation 1955; 11: 711–713.
2. Nydick I, Ruegsegger P, Wroblewski F, et al. Variations in serum glutamic oxaloacetic transaminase activity in experimental and clinical coronary insufficiency, pericarditis, and pulmonary infarction. Circulation 1957; 15: 324–334.
3. Kattus AA, Watanabe R and Semenson C. Diagnostic and prognostic significance of serum transaminase levels in coronary occlusive disease. Circulation 1957; 15: 502–511.
4. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967; 69: 696–705.
5. van der Veen KJ and Willebrands AF. Isoenzymes of creatine phosphokinase in tissue extracts and in normal and pathological sera. Clin Chim Acta 1966; 13: 312–316.
6. Cummins B, Auckland ML and Cummins P. Cardiacspecific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987; 113: 1333–1344.
7. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146–150.
8. Ebell MH, Flewelling D and Flynn CA. A systematic review of troponin T and I for diagnosing acute myocardial infarction. J Fam Pract 2000; 49: 550–556.
9. Eisenman A. Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: where do we stand? Expert Rev Cardiovasc Ther 2006; 4: 509–514.
10. de Winter RJ, Koster RW, Schotveld JH, et al. Prognostic value of troponin T, myoglobin, and CKMB mass in patients presenting with chest pain without acute myocardial infarction. Heart 1996; 75: 235–239.
11. Mills NL, Lee KK, McAllister DA, et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ 2012; 344: e1533.
12. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86.
13. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2: 349–360.
14. Bertrand ME, Rupprecht HJ, Urban P, et al. Doubleblind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000; 102: 624–629.
15. Kelley WE, Januzzi JL and Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009; 55: 2098–2112.
16. Roberts MA, Hedley AJ and Ierino FL. Understanding cardiac biomarkers in end-stage kidney disease: frequently asked questions and the promise of clinical application. Nephrology (Carlton) 2011; 16: 251–260.
17. George SK and Singh AK. Current markers of myocardial ischemia and their validity in end-stage renal disease. Curr Opin Nephrol Hypertens 1999; 8: 719–722.
18. Balamuthusamy S, Khosla S, Meka S, et al. Clinical utility of cardiac troponin I in the diagnosis of acute coronary syndrome in patients with renal failure. Am J Ther 2007; 14: 356–360.
19. Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088–3096.
20. Apple FS, Murakami MM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941–2945.
21. Wayand D, Baum H, Schatzle G, et al. Cardiac troponin T and I in end-stage renal failure. Clin Chem 2000; 46: 1345–1350.
22. Zairis MN, Tsiaousis GZ, Georgilas AT, et al. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol 2010; 141: 284–290.
23. Kaya Z, Goser S, Buss SJ, et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008; 118: 2063–2072.
24. Kaya Z, Katus HA and Rose NR. Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol 2010; 134: 80–88.
25. Yoshikawa T, Baba A and Nagatomo Y. Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 2009; 73: 602–607.
26. Smith A, John M, Trout R, et al. Elevated cardiac troponins in sepsis: what do they signify? W V Med J 2009; 105: 29–32.
27. Maeder M, Fehr T, Rickli H, et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129: 1349–1366.
28. Favory R and Neviere R. Significance and interpretation of elevated troponin in septic patients. Crit Care 2006; 10: 224.
29. Chelazzi C, Villa G and De Gaudio AR. Cardiorenal syndromes and sepsis. Int J Nephrol 2011; 2011: 652967.
30. Lim W. JOE DOUPE LECTURE: cardiac troponin in the intensive care unit. Clin Invest Med 2009; 32: E405–E410.
31. Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41: 2004–2009.
32. King DA, Codish S, Novack V, et al. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care 2005; 9: R390–R395.
33. Machado S, Roubille F, Gahide G, et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris) 2010; 59: 1–7.
34. Cohen R, Cohen-Aubart F and Steg PG. Acute pericarditis in the modern era: a diagnostic challenge. Ann Cardiol Angeiol (Paris) 2008; 57: 10–15.
35. Freixa X, Sionis A, Castel A, et al. Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis. Transplant Proc 2009; 41: 2234–2236.
36. Al-Biltagi M, Issa M, Hagar HA, et al. Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Paediatr 2010; 99: 1510–1516.
37. Sohne M, Ten Wolde M and Buller HR. Biomarkers in pulmonary embolism. Curr Opin Cardiol 2004; 19: 558–562.
38. Becattini C, Vedovati MC and Agnelli G. Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. Expert Rev Mol Diagn 2008; 8: 339–349.
39. Alonso Martinez JL, Anniccherico Sanchez FJ, Urbieta Echezarreta MA, et al. Clinical usefulness of troponin I in acute pulmonary embolism. Med Clin (Barc) 2009; 133: 201–205.
40. Becattini C, Vedovati MC and Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427–433.
41. Moores L, Aujesky D, Jimenez D, et al. Pulmonary embolism severity index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism. J Thromb Haemost 2010; 8: 517–522.
42. Krahn J, Parry DM, Leroux M, et al. High percentage of false positive cardiac troponin I results in patients with rheumatoid factor. Clin Biochem 1999; 32: 477–480.
43. Fitzmaurice TF, Brown C, Rifai N, et al. False increase of cardiac troponin I with heterophilic antibodies. Clin Chem 1998; 44: 2212–2214.